[Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment]
- PMID: 3318704
[Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment]
Abstract
The role of Interferon-beta (IFN-beta) as maintenance therapy for malignant gliomas and medulloblastomas was described. The low dose but continuous long-term administration of IFN-beta as a maintenance treatment for malignant gliomas after the induction therapy with surgery and chemoradiotherapy demonstrated the complete remission of the tumor in six cases of malignant gliomas. Such method of IFN-beta administration did not induce any serious side effects and might be useful for treatment of malignant gliomas. In addition, recent advance of adoptive immunotherapy using lymphokine activated killer cells (LAK) was briefly reviewed.
Similar articles
-
[Advances of BRM therapy of malignant brain tumors].Gan To Kagaku Ryoho. 1991 Feb;18(2):188-94. Gan To Kagaku Ryoho. 1991. PMID: 1992912 Clinical Trial. Japanese.
-
[Current status of interferon therapy on malignant brain tumor].Gan No Rinsho. 1983 May;29(6):608-15. Gan No Rinsho. 1983. PMID: 6876429 Japanese.
-
[Effect of human fibroblast interferon on malignant brain tumors].No To Shinkei. 1983 Sep;35(9):905-11. No To Shinkei. 1983. PMID: 6651989 Japanese.
-
Locoregional immunochemotherapy in hepatocellular carcinoma.Hepatogastroenterology. 2002 Jul-Aug;49(46):1109-12. Hepatogastroenterology. 2002. PMID: 12143214 Review.
-
[Treatment of children with malignant brain tumors].Gan To Kagaku Ryoho. 1999 Jul;26(8):1076-82. Gan To Kagaku Ryoho. 1999. PMID: 10431579 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical